General
Preferred name
FLUANISONE
Synonyms
Sedalande ()
Haloanison ()
R 2167 ()
R-2028 ()
NSC-170977 ()
MD-2028 ()
Fluanisona ()
R-2167 ()
MD 2028 ()
R 2028 ()
P&D ID
PD013867
CAS
1480-19-9
Tags
available
drug candidate
Drug indication
Discovery agent
Psychosis
Drug Status
experimental
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Fluanisone has potent sedative effect in vivo. Fluanisone can be used to study schizophrenia[1].
PRICE
29
DESCRIPTION
Fluanisone (Haloanison) is a butyrophenone derivative with sedative properties. It is a typical antipsychotic and is used in the treatment of schizophrenia.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
9
ChEMBL Drugs
DrugBank
DrugMAP
DrugMatrix
Ki Database
MedChem Express Bioactive Compound Library
NPC Screening Collection
ReFrame library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
21
Molecular Weight
356.19
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
0
Rotatable Bonds
7
Ring Count
3
Aromatic Ring Count
2
cLogP
3.62
TPSA
32.78
Fraction CSP3
0.38
Chiral centers
0.0
Largest ring
6.0
QED
0.71
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data
